Companies: 10,795·Total market cap: $144.5T
Iterum Therapeutics plc

Iterum Therapeutics plc

ITRMNASDAQHealthcare
$0.03
$-0.00(-10.98%)
Market Cap$1598747
P/E Ratio
52W High$1.42
52W Low$0.0271
Overview

Iterum Therapeutics plc(ITRM)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ITRM · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.75itrm eps ttm · itrm earnings per shareEarnings history
PE Ratio (TTM)itrm pe ratio ttm · itrm price to earningsPE Ratio deep dive
Revenue (TTM)390000.00itrm revenue ttm · itrm annual revenueFull revenue history
Dividend Yield不分红does itrm pay dividends · itrm dividend yieldDividend history
Shares Outstanding19.7Mitrm shares outstanding · itrm floatShares outstanding history
Next EarningsTBAitrm earnings date · itrm next earningsEarnings history

财务快照

完整财报
FY 2024Revenue$0.00
202220232024
iterum therapeutics plc revenue · itrm revenue 2024
FY 2024Net Income-$24.8M▲ +35.44% YoY
202220232024
iterum therapeutics plc net income · itrm profit 2024
FY 2024EPS$-1.26▲ +57.43% YoY
202220232024
itrm eps · iterum therapeutics plc earnings per share 2024
TTM:Revenue: $390000.00Net Income: -$27.0MEPS: $-0.75View income statement →

分析师评级与目标价

完整预测
SellBuy
Hold1 位分析师is itrm a buy · itrm analyst rating
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$0.03Current
$Avg Target
$High
itrm price target · itrm 12 month forecast

合计: 1 · 买入占比: 0.0%

股票表现

完整历史
1D+0.00%
1W+200.00%
1M-57.14%
3M-90.23%
YTD-91.04%
1Y-97.32%
5Y-99.84%

关于 Iterum Therapeutics plc

CEOCorey N. Fishman
IPO DateMay 25, 2018
Employees9
CountryIE

Iterum Therapeutics plc is a clinical-stage biopharmaceutical firm dedicated to the development and commercialization of anti-infective treatments. The company operates across Ireland, Bermuda, and th…

what is iterum therapeutics plc · itrm stock overview · iterum therapeutics plc company profile · who is iterum therapeutics plc ceo · itrm NASDAQ · iterum therapeutics plc headquarters · iterum therapeutics plc business segments

关于股票概览与关键数据

Iterum Therapeutics plc(ITRM)是 Biotechnology 行业的 Healthcare 类公司,于 May 25, 2018 在 NASDAQ 上市。截至最近交易日,ITRM 股价为 $0.03,市值约为 $1.6M。过去12个月累计回报 -97.32%,年初至今回报 -91.04%。

根据 1 位华尔街分析师,Iterum Therapeutics plc 股票共识评级为Hold,12个月平均目标价为 $—。2024 财年 Iterum Therapeutics plc 营收 —,净利润 -$24.8M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,Iterum Therapeutics plc(ITRM)股价为 $0.03,在 NASDAQ 上市,52周区间为 $0.03 – $1.42。

ITRM 最新股价ITRM quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议